FDA Orange Book
Is there a generic for Zunveyl?
Zunveyl contains benzgalantamine gluconate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Zunveyl (benzgalantamine gluconate). The Orange Book shows its last listed patent expires July 23, 2045.
Run it in Rivvi
Map Zunveyl and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Zunveyl products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, delayed release, oral | EQ 10MG BASE | Marketed (Rx) | None | 0 | None |
| tablet, delayed release, oral | EQ 15MG BASE | Marketed (Rx) | None | 0 | None |
| tablet, delayed release, oral | EQ 5MG BASE | Marketed (Rx) | None | 0 | None |
NDA 218549, held by ALPHA COGNITION INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Zunveyl patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9763953 | December 1, 2026 | Method of use | U-713 | 218549 |
| 11795176 | January 13, 2042 | Drug substance | U-713 | 218549 |
| 12208167 | February 26, 2044 | Drug product | U-713 | 218549 |
| 12551491 | July 23, 2045 | Method of use | U-713 | 218549 |
Zunveyl NDC codes
Questions
Is there a generic for Zunveyl?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Zunveyl (benzgalantamine gluconate). The Orange Book shows its last listed patent expires July 23, 2045.
What is the generic name for Zunveyl?
The active ingredient in Zunveyl is benzgalantamine gluconate, per the FDA Orange Book.
When does the Zunveyl patent expire?
The last patent listed for Zunveyl in the Orange Book expires July 23, 2045. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.